Corticosteroids: Limitations and future prospects for treatment of severe inflammatory disease

Drug Discovery Today: Therapeutic Strategies

Volumn 1, Issue 3, 2004, Pages 321-328

  Adcock, Ian M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2,3 DIHYDROBENZOFURAN 7 YL) 2 HYDROXY 3,3 DIMETHYL N (4 METHYL 1 OXO 2,3 BENZOXAZIN 6 YL) 2 TRIFLUOROMETHYLBUTANAMIDE; A 276575; AL 438; AZATHIOPRINE; BASILIXIMAB; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CMP 18; CORTICOSTEROID; CORTICOSTEROID DERIVATIVE; CYTOKINE ANTIBODY; DACLIZUMAB; DEXAMETHASONE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 2 ANTIBODY; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5 ANTIBODY; LONG ACTING DRUG; MOMETASONE FUROATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RU 40066; THEOPHYLLINE; TIPREDANE; TRIAMCINOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE; ADRENAL INSUFFICIENCY; AMNESIA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BEHAVIOR DISORDER; BONE NECROSIS; BRAIN ATROPHY; CATARACT; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DELAYED PUBERTY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RETENTION; DRUG STRUCTURE; DRUG TARGETING; DYSLIPIDEMIA; ENTERIC COATED TABLET; ENTERITIS; ERYTHEMA; GASTROINTESTINAL HEMORRHAGE; GLAUCOMA; GROWTH RETARDATION; HORMONE METABOLISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPERTRICHOSIS; HYPOGONADISM; INFECTION RISK; INFLAMMATORY DISEASE; MOOD DISORDER; MUSCLE ATROPHY; MYOPATHY; NONHUMAN; OSTEOPOROSIS; PANCREATITIS; PEPTIC ULCER; PERIORAL DERMATITIS; PETECHIA; POTASSIUM BALANCE; PSYCHOSIS; SIDE EFFECT; SKIN ATROPHY; SODIUM BALANCE; STRIA; SUSTAINED RELEASE FORMULATION; TELANGIECTASIA; THROMBOSIS; THRUSH; TREATMENT FAILURE; VASCULITIS; VIRUS REACTIVATION; WOUND HEALING IMPAIRMENT;

EID: 13344262616     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2004.11.015     Document Type: Review

References (33)

1. P.J. Barnes I.M. Adcock How do corticosteroids work in asthma? Ann. Intern. Med. 139 2003 359-370
2. I.M. Adcock Glucocorticoids: New mechanisms and future agents Curr. Allergy Asthma Rep. 3 2003 249-257
3. C. Kellendonk et al. Analysis of glucocorticoid receptor function in the mouse by gene targeting Ernst Schering Res. Found. Workshop 40 2002 305-318
4. D.Y. Leung J.W. Bloom Update on glucocorticoid action and resistance J. Allergy Clin. Immunol. 111 2003 3-22
5. I.M. Adcock S.J. Lane Corticosteroid-insensitive asthma: Molecular mechanisms J. Endocrinol. 178 2003 347-355
6. D.C. Tsitoura P.B. Rothman Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells J. Clin. Invest. 113 2004 619-627
7. T.J. Creed et al. Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis Aliment. Pharmacol. Ther. 18 2003 65-75
8. P.J. Barnes T.T. Hansel Prospects for new drugs for chronic obstructive pulmonary disease Lancet 364 2004 985-996
9. I. Rahman Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: Antioxidant therapeutic targets Curr. Drug Targets Inflamm. Allergy 1 2002 291-315
10. K. Okamoto et al. Redox-dependent regulation of nuclear import of the glucocorticoid receptor J. Biol. Chem. 274 1999 10363-10371
11. R. Chaudhuri et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma Am. J. Respir. Crit. Care Med. 168 2003 1308-1311
12. G.W. Chalmers et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma Thorax 57 2002 226-230
13. I. Rahman Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases J. Biochem. Mol. Biol. 36 2003 95-109
14. M.J. Paul-Clark et al. Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands J. Immunol. 171 2003 3245-3252
15. P.J. Barnes et al. Corticosteroid resistance in chronic obstructive pulmonary disease: Inactivation of histone deacetylase Lancet 363 2004 731-733
16. T. Chen et al. Coactivators in assay design for nuclear hormone receptor drug discovery Assay Drug Dev. Technol. 1 2003 835-842
17. H. Schacke et al. Mechanisms involved in the side effects of glucocorticoids Pharmacol. Ther. 96 2002 23-43
18. D.B. Allen et al. Inhaled corticosteroids: Past lessons and future issues J. Allergy Clin. Immunol. 112 2003 S1-S40
19. W.J. Sandborn Evidence-based treatment algorithm for mild to moderate Crohn's disease Am. J. Gastroenterol. 98 2003 S1-S5
20. G.L. Colice Comparing inhaled corticosteroids Respir. Care 45 2000 846-853
21. F. Kanniess et al. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma Pulm. Pharmacol. Ther. 14 2001 141-147
22. M. Humbert Ciclesonide: A novel inhaled corticosteroid Expert Opin. Investig. Drugs 13 2004 1349-1360
23. M. Stoeck et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide J. Pharmacol. Exp. Ther. 309 2004 249-258
24. H. Schacke H. Rehwinkel Dissociated glucocorticoid receptor ligands Curr. Opin. Investig. Drugs 5 2004 524-528
25. C.W. Lin et al. Trans-activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand
26. M.G. Belvisi et al. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity J. Immunol. 166 2001 1975-1982
27. K. Tanigawa et al. Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters Int. Immunopharmacol. 2 2002 941-950
28. R.K. Bledsoe et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition Cell 110 2002 93-105
29. P.J. Barnes Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids Eur. Respir. J. 19 2002 182-191
30. M. Roth et al. Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells N. Engl. J. Med. 351 2004 560-574
31. F. Turlais et al. High-throughput screening for identification of small-molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate) Anal. Biochem. 298 2001 62-68
32. M. Karin et al. The IKK NF-kappa B system: A treasure trove for drug development Nat. Rev. Drug Discov. 3 2004 17-26
33. E. Galli et al. Atopic dermatitis: Molecular mechanisms, clinical aspects and new therapeutical approaches Curr. Mol. Med. 3 2003 127-138